Idorsia's development compounds target a number of different diseases.

Fabry disease

Fabry disease is a rare inherited genetic disorder in which patients have a deficiency or dysfunction of an enzyme that normally breaks down a fatty waste product in the cells of the body.


Insomnia is defined as a combination of both dissatisfaction with sleep and a significant negative impact on daytime functioning. Insomnia is, worldwide, the most commonly reported sleeping disorder.

Resistant Hypertension Management

Resistant hypertension is associated with a higher risk of cardiovascular disease. In addition, patients with resistant hypertension often have a medical history of diabetes mellitus and may develop chronic kidney disease as a complication of the hypertension, increasing their vulnerability and the complexity of treatment.

Cerebral vasospasm associated with aSAH

Aneurysmal subarachnoid hemorrhage (aSAH) is a sudden life-threatening bleeding occurring in the subarachnoid space. In about one third of aSAH patients, a worsening of their condition may occur due to delayed cerebral vasospasm.

Systemic lupus erythematosus

Systemic lupus erythematosus (SLE), the most common form of Lupus, is an autoimmune disease which can affect the skin, joints, kidneys, brain and other organs.